Synthetic lethality is directly linked to TP53 because mutations or deficiencies in the TP53 gene are known to induce synthetic lethality in cells, particularly through the regulation of DNA stress checkpoints [1], [2]. Furthermore, ATR inhibition has been shown to specifically induce synthetic lethality in TP53-defective cells [3], [4].